Owner Actelion Pharmaceuticals Ltd

Inventors Richard-Bildstein, Sylvia; Dube, Daniel; Remen, Lubos; Mckay, Dan; Bur, Daniel; Scheigetz, John; Grisostomi, Corinna; Macdonald, Dwight; Corminboeuf, Olivier; Therien, Michel; Powell, David; Weller, Thomas; Bezencon, Olivier

Agent A J Park

Pub. Number AU-A-2007210813

PCT Pub. Number WO2007/088514

Priority PCT/ IB2006/050356 02.02.06 IB

Filing date 31 January 2007

Wipo publication date 9 August 2007

C07D 211/70 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 211/34 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups